Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H17NO |
Molecular Weight | 191.2695 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)C1=CC(C)=CC=C1
InChI
InChIKey=MMOXZBCLCQITDF-UHFFFAOYSA-N
InChI=1S/C12H17NO/c1-4-13(5-2)12(14)11-8-6-7-10(3)9-11/h6-9H,4-5H2,1-3H3
Molecular Formula | C12H17NO |
Molecular Weight | 191.2695 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/mmx/diethyltoluamide.htmlCurator's Comment: description was created based on several sources, including:
https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/deet_508.pdf | https://www.epa.gov/insect-repellents/deet | http://www.swmosquito.org/pdf/PROT_DEET%20Toxicity.pdf
Sources: https://www.drugs.com/mmx/diethyltoluamide.html
Curator's Comment: description was created based on several sources, including:
https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/deet_508.pdf | https://www.epa.gov/insect-repellents/deet | http://www.swmosquito.org/pdf/PROT_DEET%20Toxicity.pdf
Diethyltoluamide (DEET) is an insect repellent used to keep insects away. This product is effective against mosquitoes, biting flies (gnats, sandflies, deer flies, stable flies, black flies), ticks, harvest mites, and fleas. DEET is absorbed through the skin. DEET has few adverse effects when applied as directed. The most common problem is local skin irritation, including erythema and pruritis, at the site of application.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: 1279770.0 Gene Symbol: OBP17 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21671117 |
31.3 µM [Kd] | ||
Target ID: OR136 (Culex quinquefasciatus) Sources: https://www.ncbi.nlm.nih.gov/pubmed/25349401 |
|||
Target ID: Ionotropic receptor 40a (Fruit fly) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24089210 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseDEET to protect humans from mosquito-borne illnesses like West Nile Virus, the Zika virus or malaria and tick-borne illnesses like Lyme disease and Rocky Mountain spotted fever. |
|||
Preventing | Unknown Approved UseDEET to protect humans from mosquito-borne illnesses like West Nile Virus, the Zika virus or malaria and tick-borne illnesses like Lyme disease and Rocky Mountain spotted fever. |
|||
Preventing | Unknown Approved UseDEET to protect humans from mosquito-borne illnesses like West Nile Virus, the Zika virus or malaria and tick-borne illnesses like Lyme disease and Rocky Mountain spotted fever. |
PubMed
Title | Date | PubMed |
---|---|---|
Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination. | 2001 Apr |
|
Induction of urinary excretion of 3-nitrotyrosine, a marker of oxidative stress, following administration of pyridostigmine bromide, DEET (N,N-diethyl-m-toluamide) and permethrin, alone and in combination in rats. | 2001 Apr 30 |
|
Isolation of a deet-insensitive mutant of Drosophila melanogaster (Diptera: Drosophilidae). | 2001 Dec |
|
Laboratory & field evaluation of controlled release formulation of the insect repellents N,N-diethyl-m-toluamide (DEET) & N,N-diethyl phenylacetamide (DEPA) against mosquito vectors. | 2001 Mar |
|
Disruption of the blood-brain barrier and neuronal cell death in cingulate cortex, dentate gyrus, thalamus, and hypothalamus in a rat model of Gulf-War syndrome. | 2002 Aug |
|
Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. | 2002 Aug 5 |
|
Repellent activities of essential oils and monoterpenes against Culex pipiens pallens. | 2002 Dec |
|
Topical formulation studies with DEET (N,N-diethyl-3-methylbenzamide) and cyclodextrins. | 2002 Jan |
|
Binding of pyridostigmine bromide, N,N-diethyl-m-toluamide and permethrin, alone and in combinations, to human serum albumin. | 2002 May |
|
Analysis of N,N-diethyl-m-toluamide in porcine skin perfusates using solid-phase extraction disks and reversed-phase high-performance liquid chromatography. | 2002 Nov 15 |
|
Gulf War related exposure factors influencing topical absorption of 14C-permethrin. | 2002 Sep 5 |
|
Combined exposure to DEET (N,N-diethyl-m-toluamide) and permethrin: pharmacokinetics and toxicological effects. | 2003 Jan-Feb |
|
Analysis and mass spectrometric characterization of the insect repellent Bayrepel and its main metabolite Bayrepel-acid. | 2004 Aug 13 |
|
Evaluation of the sensitivity of Aedes aegypti and Anopheles gambiae complex mosquitoes to two insect repellents: DEET and KBR 3023. | 2004 Mar |
|
Active ingredients in sunscreens act as topical penetration enhancers for the herbicide 2,4-dichlorophenoxyacetic acid. | 2004 Mar 15 |
|
Comparative resistance of Anopheles albimanus and Aedes aegypti to N,N-diethyl-3-methylbenzamide (Deet) and 2-methylpiperidinyl-3-cyclohexen-1-carboxamide (AI3-37220) in laboratory human-volunteer repellent assays. | 2004 May |
|
In-vitro permeation of the insect repellent N,N-diethyl-m-toluamide (DEET) and the sunscreen oxybenzone. | 2004 May |
|
Biodegradation of the insecticide N,N-diethyl-m-toluamide by fungi: identification and toxicity of metabolites. | 2005 Apr |
|
Insect repellents, phenoxyherbicide exposure, and non-Hodgkin's lymphoma. | 2005 Aug |
|
Field evaluation of commercial repellent formulations against mosquitoes (Diptera: Culicidae) in Northern Territory, Australia. | 2005 Dec |
|
Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drugs N,N-diethyl-m-toluamide and vitamin K. | 2005 Dec |
|
Nitric oxide regulates prolidase activity by serine/threonine phosphorylation. | 2005 Dec 1 |
|
The metabolism of nonane, a JP-8 jet fuel component, by human liver microsomes, P450 isoforms and alcohol dehydrogenase and inhibition of human P450 isoforms by JP-8. | 2005 Feb 10 |
|
Feeding deterrent effects of catnip oil components compared with two synthetic amides against Aedes aegypti. | 2005 Jul |
|
Widespread detection of N,N-diethyl-m-toluamide in U.S. streams: comparison with concentrations of pesticides, personal care products, and other organic wastewater compounds. | 2005 May |
|
Comparison of contact and spatial repellency of catnip oil and N,N-diethyl-3-methylbenzamide (deet) against mosquitoes. | 2005 May |
|
Evaluation of West Nile virus education campaign. | 2005 Nov |
|
Bioengineering of a cellulosic fabric for insecticide delivery via grafted cyclodextrin. | 2005 Nov-Dec |
|
Field-user acceptability of new camouflage face paint formulations in the Republic of Korea. | 2005 Oct |
|
Repellent efficacy of four commercial DEET lotions against Amblyomma hebraeum (Acari: Ixodidae), the principal vector of Rickettsia africae in southern Africa. | 2005 Sep |
|
Mosquito repellents and superwarfarin rodenticides--are they really toxic in children? | 2006 Apr |
|
Initial evaluation of N,N-diethyl-m-toluamide and permethrin absorption in human volunteers under stress conditions. | 2006 Feb |
|
Repelling properties of some plant materials on the tick Ixodes ricinus L. | 2006 Jan |
|
Hodgkin lymphoma, multiple myeloma, soft tissue sarcomas, insect repellents, and phenoxyherbicides. | 2006 Mar |
Patents
Sample Use Guides
Sparingly to exposed area(s) of skin. Reapply when necessary. Use a product that contains low amounts (less than 30%) of diethyltoluamide. One application using a product that contains low amounts of diethyltoluamide will last about 4 to 8 hours.
Route of Administration:
Topical
DEET-containing formulations applied at a concentration of 320-360 ug/cm^2 1.6 (7-1.88 uM/cm^2) using human and pig skin. A minimum evaporation rate of 5 ug/cm^2/h (0.03 uM/cm^2/h) for DEET over 5-15 minutes was determined for human and pig skin. In vitro, penetration of DEET in the mouse (33.3 ug/cm^2; 0.174 uM/cm^2), rat (38.7 ug/cm^2; 0.202 uM/cm^2), hairless guinea pig (12.5 ug/cm^2; 0.0653 uM/cm^2), pig (19.4 ug/cm^2; 0.101 uM/cm^2), human (44.7 ug/cm^2; 0.234 uM/cm^2), as well as cultured human skin (27.9 ug/cm^2; 0.146 uM/cm^2) was assessed using an automated, flow-through skin penetration apparatus (AIDA).
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 16 16:42:32 UTC 2022
by
admin
on
Fri Dec 16 16:42:32 UTC 2022
|
Record UNII |
FB0C1XZV4Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
P03BX01
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
||
|
EPA PESTICIDE CODE |
80301
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
||
|
NCI_THESAURUS |
C737
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
||
|
WHO-VATC |
QP53GX01
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
134-62-3
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
Diethyltoluamide
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
diethyltoluamide
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
3129
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | RxNorm | ||
|
FB0C1XZV4Y
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
DIETHYLTOLUAMIDE
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | Description: Colourless or faintly yellow liquid.Solubility: Practically immiscible in water and glycerol R; miscible with ethanol (~750 g/l) TS and ether R.Category: Insect repellent.Storage: Diethyltoluamide should be kept in a tightly closed container.Additional information: CAUTION: Diethyltoluamide is an irritant to eyes and mucous membranes.Requirements: Diethyltoluamide contains not less than 97.0% and not more than 103.0% of C12H17NO, calculated with reference to the anhydrous substance. | ||
|
33840
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
7071
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
6685
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
FB0C1XZV4Y
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
4418
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
DB11282
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
4284
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
SUB07114MIG
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
DTXSID2021995
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
205-149-7
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
D003671
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
M4129
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | Merck Index | ||
|
C80601
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
DEET
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
1197007
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
CHEMBL1453317
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY | |||
|
1582
Created by
admin on Fri Dec 16 16:42:32 UTC 2022 , Edited by admin on Fri Dec 16 16:42:32 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
IN VITRO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |